Literature DB >> 17628626

Corepressors of agonist-bound nuclear receptors.

Igor Gurevich1, Anthony M Flores, Brian J Aneskievich.   

Abstract

Nuclear receptors (NRs) rely on coregulator proteins to modulate transcription of target genes. NR coregulators can be broadly subdivided into coactivators which potentiate transcription and corepressors which silence gene expression. The prevailing view of coregulator action holds that in the absence of agonist the receptor interacts with a corepressor via the corepressor nuclear receptor (CoRNR, "corner") box motifs within the corepressor. Upon agonist binding, a conformational change in the receptor causes the shedding of corepressor and the binding of a coactivator which interacts with the receptor via NR boxes within the coregulator. This view was challenged with the discovery of RIP140 which acts as a NR corepressor in the presence of agonist and utilizes NR boxes. Since then a number of other corepressors of agonist-bound NRs have been discovered. Among them are LCoR, PRAME, REA, MTA1, NSD1, and COPR1 Although they exhibit a great diversity of structure, mechanism of repression and pathophysiological function, these corepressors frequently have one or more NR boxes and often recruit histone deacetylases to exert their repressive effects. This review highlights these more recently discovered corepressors and addresses their potential functions in transcription regulation, disease pharmacologic responses and xenobiotic metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628626      PMCID: PMC2148130          DOI: 10.1016/j.taap.2007.05.019

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  57 in total

1.  MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers.

Authors:  Ki-Seok Jang; Seung Sam Paik; Heekyoung Chung; Young-Ha Oh; Gu Kong
Journal:  Cancer Sci       Date:  2006-05       Impact factor: 6.716

Review 2.  Controlling nuclear receptors: the circular logic of cofactor cycles.

Authors:  Valentina Perissi; Michael G Rosenfeld
Journal:  Nat Rev Mol Cell Biol       Date:  2005-07       Impact factor: 94.444

3.  Isolation and functional analysis of a keratinocyte-derived, ligand-regulated nuclear receptor comodulator.

Authors:  Anthony M Flores; Lu Li; Brian J Aneskievich
Journal:  J Invest Dermatol       Date:  2004-12       Impact factor: 8.551

4.  The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.

Authors:  Mirjam T Epping; Liming Wang; Michael J Edel; Leone Carlée; Maria Hernandez; René Bernards
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

5.  Rifampicin induction of CYP3A4 requires pregnane X receptor cross talk with hepatocyte nuclear factor 4alpha and coactivators, and suppression of small heterodimer partner gene expression.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Drug Metab Dispos       Date:  2006-02-02       Impact factor: 3.922

6.  The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene.

Authors:  Olivier Barbier; Lyne Villeneuve; Virginie Bocher; Coralie Fontaine; Ines Pineda Torra; Christian Duhem; Vladimir Kosykh; Jean-Charles Fruchart; Chantal Guillemette; Bart Staels
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

7.  Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity.

Authors:  Yuzhi Jia; Grace L Guo; Sailesh Surapureddi; Joy Sarkar; Chao Qi; Dongsheng Guo; Jun Xia; Papreddy Kashireddi; Songtao Yu; Young-Wook Cho; M Sambasiva Rao; Byron Kemper; Kai Ge; Frank J Gonzalez; Janardan K Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

8.  Retinoic acid induces corneal epithelial CYP4B1 gene expression and stimulates the synthesis of inflammatory 12-hydroxyeicosanoids.

Authors:  Silvia Ashkar; Alexandre Mesentsev; Wen-Xiang Zhang; Vladimir Mastyugin; Michael W Dunn; Michal Laniado-Schwartzman
Journal:  J Ocul Pharmacol Ther       Date:  2004-02       Impact factor: 2.671

9.  Human CYP1B1 is regulated by estradiol via estrogen receptor.

Authors:  Yuki Tsuchiya; Miki Nakajima; Satoru Kyo; Taro Kanaya; Masaki Inoue; Tsuyoshi Yokoi
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 10.  Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer.

Authors:  Daniel W Nebert; Timothy P Dalton; Allan B Okey; Frank J Gonzalez
Journal:  J Biol Chem       Date:  2004-03-17       Impact factor: 5.157

View more
  28 in total

1.  TNIP1, a retinoic acid receptor corepressor and A20-binding inhibitor of NF-κB, distributes to both nuclear and cytoplasmic locations.

Authors:  Igor Gurevich; Carmen Zhang; Nidhish Francis; Brian J Aneskievich
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

2.  PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1.

Authors:  Igor Gurevich; Carmen Zhang; Priscilla C Encarnacao; Charles P Struzynski; Sarah E Livings; Brian J Aneskievich
Journal:  Biochim Biophys Acta       Date:  2011-10-07

3.  RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.

Authors:  Waise Quarni; Panida Lungchukiet; Anfernee Tse; Pei Wang; Yuefeng Sun; Ravi Kasiappan; Jheng-Yu Wu; Xiaohong Zhang; Wenlong Bai
Journal:  J Steroid Biochem Mol Biol       Date:  2017-02-01       Impact factor: 4.292

4.  RaRF confers RA resistance by sequestering RAR to the nucleolus and regulating MCL1 in leukemia cells.

Authors:  H Youn; H-K Lee; H-R Sohn; U-H Park; E-J Kim; B Youn; S-J Um
Journal:  Oncogene       Date:  2017-09-25       Impact factor: 9.867

5.  Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.

Authors:  Xavier C Giner; David Cotnoir-White; Sylvie Mader; Daniel Lévesque
Journal:  FASEB J       Date:  2015-07-06       Impact factor: 5.191

Review 6.  Headway and hurdles in the clinical development of dietary phytochemicals for cancer therapy and prevention: lessons learned from vitamin A derivatives.

Authors:  Christina Y Yim; Pingping Mao; Michael J Spinella
Journal:  AAPS J       Date:  2014-01-16       Impact factor: 4.009

Review 7.  Deconstructing repression: evolving models of co-repressor action.

Authors:  Valentina Perissi; Kristen Jepsen; Christopher K Glass; Michael G Rosenfeld
Journal:  Nat Rev Genet       Date:  2010-02       Impact factor: 53.242

8.  NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.

Authors:  Ayano Murai-Takeda; Hirotaka Shibata; Isao Kurihara; Sakiko Kobayashi; Kenichi Yokota; Noriko Suda; Yuko Mitsuishi; Rie Jo; Hirochika Kitagawa; Shigeaki Kato; Takao Saruta; Hiroshi Itoh
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

9.  ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1.

Authors:  Sang-Wang Lee; Yang-Sook Cho; Jung-Min Na; Ui-Hyun Park; Myengmo Kang; Eun-Joo Kim; Soo-Jong Um
Journal:  J Biol Chem       Date:  2009-10-31       Impact factor: 5.157

10.  Retinoic acid mediates long-paced oscillations in retinoid receptor activity: evidence for a potential role for RIP140.

Authors:  Kelly C Heim; Joshua J Gamsby; Mary P Hever; Sarah J Freemantle; Jennifer J Loros; Jay C Dunlap; Michael J Spinella
Journal:  PLoS One       Date:  2009-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.